John A. Foekens
Erasmus MC-Daniel den Hoed
Department of Medical Oncology
3000 DR Rotterdam
Netherlands
Name/email consistency: high
- The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer. Foekens, J.A., Ries, C., Look, M.P., Gippner-Steppert, C., Klijn, J.G., Jochum, M. Cancer Res. (2003)
- Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy. Foekens, J.A., Romain, S., Look, M.P., Martin, P.M., Klijn, J.G. Cancer Res. (2001)
- High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. Foekens, J.A., Peters, H.A., Grebenchtchikov, N., Look, M.P., Meijer-van Gelder, M.E., Geurts-Moespot, A., van der Kwast, T.H., Sweep, C.G., Klijn, J.G. Cancer Res. (2001)
- The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Foekens, J.A., Peters, H.A., Look, M.P., Portengen, H., Schmitt, M., Kramer, M.D., Brünner, N., Jänicke, F., Meijer-van Gelder, M.E., Henzen-Logmans, S.C., van Putten, W.L., Klijn, J.G. Cancer Res. (2000)
- Prognostic value of CD44 variant expression in primary breast cancer. Foekens, J.A., Dall, P., Klijn, J.G., Skroch-Angel, P., Claassen, C.J., Look, M.P., Ponta, H., Van Putten, W.L., Herrlich, P., Henzen-Logmans, S.C. Int. J. Cancer (1999)
- Prognostic significance of cathepsins B and L in primary human breast cancer. Foekens, J.A., Kos, J., Peters, H.A., Krasovec, M., Look, M.P., Cimerman, N., Meijer-van Gelder, M.E., Henzen-Logmans, S.C., van Putten, W.L., Klijn, J.G. J. Clin. Oncol. (1998)